Pharmacovigilance

Pharmacovigilance is the scientific discipline comprising systematic detection, assessment, understanding, and prevention of adverse effects or any other drug-related problem associated with pharmaceutical products in clinical use.

22.9K

Publications

1.4M

Citations

106.2K

Authors

13.3K

Institutions

Publications per year

2017–2026

7.6K

Authors

106.2K

  1. JR
    Julio Rosenstock

    Dallas Diabetes Research Center, United States

    79 publications · 15K citations

    55

    h-index

  2. GY
    Gregory Y.H. Lip

    Aalborg University, Denmark

    79 publications · 5.8K citations

    40

    h-index

  3. MS
    Miriam Sturkenboom

    Erasmus MC, Netherlands

    67 publications · 4.7K citations

    39

    h-index

  4. JM
    Jean‐Louis Montastruc

    Inserm, France

    74 publications · 3.1K citations

    37

    h-index

  5. ML
    Maryse Lapeyre‐Mestre

    Inserm, France

    67 publications · 3.1K citations

    36

    h-index

1–5 of 106.2K

Venues

  1. Diabetes Care

    189 publications · 30.7K citations

    102

    h-index

  2. JAMA

    240 publications · 65K citations

    102

    h-index

  3. PubMed

    Repository · 1.2K publications · 48.7K citations

    90

    h-index

  4. British Journal of Clinical Pharmacology

    BJCP · 473 publications · 27.8K citations

    83

    h-index

  5. New England Journal of Medicine

    NEJM · 121 publications · 68K citations

    81

    h-index

1–5

See also

Pharmacovigilance

Core Methods

Data Sources

Regulatory Frameworks

Applications

Challenges